Complement-coated antibody-transfer (CCAT); Serum IgA1 antibodies intercept and transport C4 and C3 fragments and preserve IgG1 deployment (PGD)

Molecular Immunology

Volumn 43, Issue 3, 2006, Pages 236-245

  Boackle, Robert J ^a,b   Nguyen, Quang L ^a   Leite, Renata S ^a,b   Yang, Xiaofeng ^a   Vesely, Jana ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

C1q; C3b; C4b; Complement; IgA1; IgG1; Periodontal disease

Indexed keywords

CARBOHYDRATE; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C4B; COMPLEMENT FACTOR I; DANSYL CHLORIDE; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G1;

ADDITION REACTION; ANTIBODY BLOOD LEVEL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; COVALENT BOND; DISSOLUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNCTIONAL ASSESSMENT; GENETIC ENGINEERING; HUMAN; IMMOBILIZATION; IMMUNOSTIMULATION; INCUBATION TIME; LIQUID; LONG TERM EXPOSURE; MATERIAL COATING; MICROTITER PLATE ASSAY; MUTANT; OBSERVATION; PASSIVE IMMUNIZATION; PRESERVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; SURFACE PROPERTY;

ANTIGENS; BIOLOGICAL TRANSPORT; COMPLEMENT C3C; COMPLEMENT C3D; COMPLEMENT C4B; COMPLEMENT PATHWAY, CLASSICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; KINETICS; PERIODONTAL DISEASES;

EID: 25644455328     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2005.02.004     Document Type: Article

References (43)

1. G. Ambrus, P. Gal, M. Kojima, K. Szilagyi, J. Balczer, J. Antal, L. Graf, A. Laich, B.E. Moffatt, W. Schwaeble, R.B. Sim, and P. Zavodszky Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments J. Immunol. 170 2003 1374 1382
2. Z. Bajtay, C. Speth, A. Erdei, and M.P. Dierich Productive HIV-1 infection of dendritic cells via complement receptor type 3 (CR3, CD11b/CD18) J. Immunol. 173 2004 4775 4778
3. R.J. Boackle, K.M. Pruitt, and J. Mestecky The interactions of human complement with interfacially aggregated preparations of human secretory IgA Immunochemistry 11 1974 543 548
4. R.J. Boackle, M.H. Connor, and J. Vesely High molecular weight non immunoglobulin salivary agglutinins (NIA) bind C1q globular heads and have the potential to activate the first complement component Mol. Immunol. 30 1993 309 319
5. M.F. Burritt, N.J. Calvanico, S. Mehta, and T.B. Tomasi Activation of the classical complement pathway by Fc fragment of Human IgA J. Immunol. 118 1976 723 725
6. 2 complex from immobilized human IgG subclasses Clin. Immunol. Immunopathol. 87 1998 68 74
7. 2 complex from anti-C1Q monoclonal antibodies with low binding affinities Immunology 95 1998 648 654
8. P.D. Chuang, and S.L. Morrison Elimination of N-linked glycosylation sites from the human IgA1 constant region: effects on structure and function J. Immunol. 158 1997 724 732
9. S.L. Dillman, A.J. Strelkauskas, H.R. Su, and R.J. Boackle Activation of human complement by totally human monoclonal antibodies Mol. Immunol. 32 1995 957 964
10. E.V. Frandsen, J. Reinholdt, M. Kjeldsen, and M. Kilian In vivo cleavage of immunoglobulin A1 by immunoglobulin A1 proteases from Prevotella and Capnocytophaga species Oral Microbiol. Immunol. 10 1995 291 296
11. H. Hawlisch, M. Wills-Karp, C.L. Karp, and J. Kohl The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma Mol. Immunol. 41 2004 123 131
12. P.S. Hiemstra, J. Biewenga, A. Gorter, M.E. Stuurman, A. Faber, L.A. van Es, and M.R. Daha Activation of complement by human serum IgA, secretory IgA and IgA1 fragments Mol. Immunol. 25 1988 527 533
13. P.S. Hiemstra, A. Gorter, M.E. Stuurman, L.A. van Es, and M.R. Daha Activation of the alternative pathway of complement by human serum IgA Eur. J. Immunol. 17 1987 321 326
14. M.A. Hietala, K.S. Nandakumar, L. Persson, S. Fahlen, R. Holmdahl, and M. Pekna Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis Eur. J. Immunol. 34 2004 1208 1216
15. C. Horgan, K. Brown, and S.H. Pincus Effect of H chain V region on complement activation by immobilized immune complexes J. Immunol. 149 1992 127 135
16. H. Imai, A. Chen, R.J. Wyatt, and A. Rifai Lack of complement activation by IgA immune complexes Clin. Exp. Immunol. 73 1988 479 483
17. E.N. Janoff, C. Fasching, J.M. Orenstein, J.B. Rubins, N.L. Opstad, and A.P. Dalmasso Killing of streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes J. Clin. Invest. 104 1999 1139 1147
18. M. Kilian, B. Ellegaard, and J. Mestecky Distribution of immunoglobulin isotypes including IgA subclasses in adult, juvenile and rapidly progressive periodontitis J. Clin. Periodontol. 16 1989 179 184
19. D.F. Kinane, D.F. Lappin, O. Koulouri, and A. Buckley Humoral immune responses in periodontal disease may have mucosal and systemic immune features Clin. Exp. Immunol. 115 1999 534 541
20. P.J. Lachmann Microbial subversion of the immune response Proc. Natl. Acad. Sci. U.S.A. 99 2002 8461 8462
21. T. Matsuyama, T. Kawai, Y. Izumi, and M.A. Taubman Expression of major histocompatibility complex class II and CD80 by gingival epithelial cells induces activation of CD4+ T cells in response to bacterial challenge Infect. Immun. 73 2005 1044 1051
22. S. Mazzoli, L. Lopalco, A. Salvi, D. Trabattoni, S. Lo Caputo, F. Semplici, M.Bl.C. Biasin, A. Cosma, C. Pastori, F. Meacci, F. Mazzotta, M.L. Villa, A.G. Siccardi, and M. Clerici Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons J. Infect. Dis. 180 1999 871 875
23. V.D. Miletic, C.G. Hester, and M.M. Frank Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes J. Immunol. 156 1996 749 757
24. H.C. Morton, J.D. Atkin, R.J. Owens, and J.M. Woof Purification and characterization of chimeric human IgA1 and IgA2 expressed in COS and Chinese hamster ovary cells J. Immunol. 151 1993 4743 4752
25. E.B. Nikolova, M. Tomana, and M.W. Russell All forms of human IgA antibodies bound to antigen interfere with complement C3 fixation induced by IgG or by antigen alone Scand. J. Immunol. 39 1994 275 280
26. T. Ogawa, M.L. McGhee, Z. Moldoveanu, S. Hamada, J. Mestecky, J.R. McGhee, and H. Kiyono Bacteroides-specific IgG and IgA subclass antibody-secreting cells isolated from chronically inflamed gingival tissues Clin. Exp. Immunol. 76 1989 103 110
27. A. Roberts, M. Shah, and I.L. Chapple C-1 esterase inhibitor dysfunction localized to the periodontal tissues: clues to the role of stress in the pathogenesis of chronic periodontitis? J. Clin. Periodontol. 30 2003 271 277
28. A. Roos, L.H. Bouwman, D.J. van Gijlswijk-Janssen, M.C. Faber-Krol, G.L. Stahl, and M.R. Daha Human IgA activates the complement system via the mannan-binding lectin pathway J. Immunol. 167 2001 2861 2868
29. M.W. Russell, and B. Mansa Complement-fixing properties of human IgA antibodies. Alternative pathway complement activation by plastic-bound, but not specific antigen-bound, IgA Scand. J. Immunol. 30 1989 175 183
30. M.W. Russell, J. Reinholdt, and M. Killian Anti-Inflammatory activity of human IgA antibodies and their Fab-alpha fragments: inhibition of IgG-mediated complement activation Eur. J. Immunol. 19 1989 2244 2249
31. H.A. Schenkein, H.M. Fletcher, M. Bodnar, and F.L. Macrina Increased opsonization of a prtH-defective mutant of Porphyromonas gingivalis W83 is caused by reduced degradation of complement-derived opsonins J. Immunol. 154 1995 5331 5337
32. V.N. Schumaker, D.C. Hanson, E. Kilchherr, M.L. Phillips, and P.H. Poon A molecular mechanism for the activation of the first component of complement by immune complexes Mol. Immunol. 23 1986 557 565
33. J.M. Shohet, P. Pemberton, and M.C. Carroll Identification of a major binding site for complement C3 on the IgG1 heavy chain J. Biol. Chem. 268 1993 5866 5871
34. R.J. Sokol, D.J. Booker, R. Stamps, J.R. Booth, and V. Hook IgA red cell autoantibodies and autoimmune hemolysis Transfusion 37 1997 175 181
35. H. Stoiber, C. Speth, and M.P. Dierich Role of complement in the control of HIV dynamics and pathogenesis Vaccine 21 Suppl. 2 2003 S77 S82
36. J.F. Suber, R.J. Boackle, T. Javed, and J. Vesely Parotid salivary agglutinins for sheep erythrocytes as a measure of ongoing inflammation in periodontal diseases J. Periodontol. 55 1984 512 515
37. K. Takahashi, J. Mooney, E.V. Frandsen, and D.F. Kinane IgG and IgA subclass mRNA-bearing plasma cells in periodontitis gingival tissue and immunoglobulin levels in the gingival crevicular fluid Clin. Exp. Immunol. 107 1997 158 165
38. M. van Egmond, A.B. van Spriel, H. Vermeulen, G. Huls, E. van Garderen, and J.G. van de Winkel Enhancement of polymorphonuclear cell-mediated tumor cell killing on simultaneous engagement of fcgammaRI (CD64) and fcalphaRI (CD89) Cancer Res. 61 2001 4055 4060
39. M.J. Walport, and P.J. Lachmann Erythrocyte complement receptor 1, immune complexes, and the rheumatic diseases Arthritis Rheum. 31 1988 153 158
40. W. Zhang, and P.J. Lachmann Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes Immunology 81 1994 137 141
41. W. Zhang, and P.J. Lachmann Neutrophil lactoferrin release induced by IgA immune complexes can be mediated either by Fc alpha receptors or by complement receptors through different pathways J. Immunol. 156 1996 2599 2606
42. R.J. Ziccardi Studies on the mechanism of C3b inhibition of immune complex induced C1 activation Mol. Immunol. 12 1988 1339 1346
43. R.J. Ziccardi Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition J. Immunol. 136 1986 3378 3383